Last reviewed · How we verify

Tea tree oil vagitories

University of Sarajevo · FDA-approved active Small molecule

Tea tree oil vagitories deliver antimicrobial and anti-inflammatory compounds directly to vaginal tissue to treat infections and inflammation.

Tea tree oil vagitories deliver antimicrobial and anti-inflammatory compounds directly to vaginal tissue to treat infections and inflammation. Used for Vaginal infections (bacterial vaginosis, candidiasis, trichomoniasis), Vaginal inflammation and irritation.

At a glance

Generic nameTea tree oil vagitories
SponsorUniversity of Sarajevo
Drug classHerbal antimicrobial vaginal suppository
ModalitySmall molecule
Therapeutic areaGynecology / Infectious Disease
PhaseFDA-approved

Mechanism of action

Tea tree oil contains terpineol and other volatile compounds with documented antimicrobial activity against bacteria, fungi, and some viruses. When formulated as vaginal suppositories, these compounds are released locally to reduce pathogenic microorganisms and modulate local inflammatory responses. The mechanism is primarily antimicrobial rather than receptor-mediated.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: